ICMR licensed three indigenous biomedical technologies to Emcure and Biological E, advancing an HPV precancer therapy and vaccines for typhoid, paratyphoid and Shigella toward affordable commercial ...
In January 2025, Linda-Gail Bekker stood inside a vaccine manufacturing plant and allowed herself to believe that the first ...
The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for India's first dengue vaccine, ...
Vietnam Investment Review on MSN
Takeda's dengue vaccine wins India's first approval
NEW DELHI, July 21, 2026 /PRNewswire/ -- Takeda today announced that India's Drug Controller General of India (DCGI) has granted marketing authorization for Takeda's dengue vaccine (TAK-003) for the ...
KC BioHub received $34 million from the commerce department to improve biological manufacturing, supply chains and research.
Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary ...
Cecilia Ramirez spends her summer crisscrossing the Oklahoma City area. She drives a van decorated with smiling cartoon kids ...
Public health agencies are urging continued vigilance regarding the Zika virus, a mosquito-borne illness that remains a ...
Japanese drugmaker Takeda Pharmaceutical's dengue vaccine QDENGA has been approved by India's drug regulator, making ...
A new study has found that creatine can provide a crucial energy boost to key immune cells, allowing them to effectively ...
A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...
A first-in-human KRAS-targeted pancreatic cancer vaccine elicited durable immune responses in 90% of participants, and slowed precancerous lesions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results